Ellagic acid-induced thrombotic focal cerebral ischemic model in rats

Journal of Pharmacological and Toxicological Methods

Volumn 69, Issue 3, 2014, Pages 217-222

  Pang, Xiaoming ^a   Li, Tianxia ^a   Feng, Liuxin ^a   Zhao, Jingjing ^a   Zhang, Xiaolu ^a   Liu, Juntian ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Animal model; Ellagic acid; Focal cerebral ischemia; Stroke

Indexed keywords

BLOOD CLOTTING FACTOR 12; ELLAGIC ACID; LACTATE DEHYDROGENASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIPHENYLTETRAZOLIUM; TETRAZOLIUM;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BODY WEIGHT; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; BRAIN WEIGHT; CEREBRAL ARTERY DISEASE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MICROSCOPY; NEUROLOGIC DISEASE; NONHUMAN; RAT; SPECTROPHOTOMETRY; STAINING; THROMBOTIC FOCAL CEREBRAL ISCHEMIA; ANIMAL; BLOOD; BRAIN; CEREBROVASCULAR ACCIDENT; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; TOXICITY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; RATS; RATS, SPRAGUE-DAWLEY; STROKE; SUPEROXIDE DISMUTASE; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 84896307662     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2014.01.001     Document Type: Article

References (28)

1. Aygul R., Kotan D., Demirbas F., Ulvi H., Deniz O. Plasma oxidants and antioxidants in acute ischaemic stroke. The Journal of International Medical Research 2006, 34:413-418.
2. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
3. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996, 27:1616-1622.
4. Botti R.E. Assessment of the hypercoagulable state and ellagic acid. Thrombosis et Diathesis Haemorrhagica. Supplementum 1966, 20:49-52.
5. Castillo J., Davalos A., Marrugat J., Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998, 29:2455-2460.
6. Chen H., Yoshioka H., Kim G.S., Jung J.E., Okami N., Sakata H., et al. Oxidative stress in ischemic brain damage: Mechanisms of cell death and potential molecular targets for neuroprotection. Antioxidants & Redox Signaling 2011, 14:1505-1517.
7. Damas J., Remacle-Volon G., Adam A. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid. Advances in Experimental Medicine and Biology 1989, 247A:461-465.
8. Durukan A., Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology, Biochemistry, and Behavior 2007, 87:179-197.
9. Girolami A., Cella G., Burul A., Zucchetto M. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state. Folia Haematologica (Leipzig, Germany: 1928) 1976, 103:261-270.
10. Hall E.D., Braughler J.M. Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radical Biology & Medicine 1989, 6:303-313.
11. Hara T., Iwamoto M., Ishihara M., Tomikawa M. Preventive effect of argatroban on ellagic acid-induced cerebral thromboembolism in rats. Haemostasis 1994, 24:351-357.
12. Huang N.C., Wei J., Quast M.J. A comparison of the early development of ischemic brain damage in normoglycemic and hyperglycemic rats using magnetic resonance imaging. Experimental Brain Research 1996, 109:33-42.
13. Iomhair M.M., Lavelle S.M. Effect of aspirin-dipyridamole and heparin and their combination on venous thrombosis in hypercoagulable or thrombotic animals. Thrombosis Research 1996, 82:479-483.
14. Kudo M., Aoyama A., Ichimori S., Fukunaga N. An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke 1982, 13:505-508.
15. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
16. MacLellan C.L., Davies L.M., Fingas M.S., Colbourne F. The influence of hypothermia on outcome after intracerebral hemorrhage in rats. Stroke 2006, 37:1266-1270.
17. Mergenthaler P., Dirnagl U., Meisel A. Pathophysiology of stroke: Lessons from animal models. Metabolic Brain Disease 2004, 19:151-167.
18. Mhairi Macrae I. New models of focal cerebral ischaemia. British Journal of Clinical Pharmacology 1992, 34:302-308.
19. Mukherjee D., Patil C.G. Epidemiology and the global burden of stroke. World Neurosurgery 2011, 76:S85-S90.
20. Nedergaard M. Transient focal ischemia in hyperglycemic rats is associated with increased cerebral infarction. Brain Research 1987, 408:79-85.
21. Ratnoff O.D., Crum J.D. Activation of Hageman factor by solutions of ellagic acid. The Journal of Laboratory and Clinical Medicine 1964, 63:359-377.
22. Ratnoff O.D., Saito H. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid. The Journal of Laboratory and Clinical Medicine 1982, 100:248-260.
23. Reith J., Jorgensen H.S., Pedersen P.M., Nakayama H., Raaschou H.O., Jeppesen L.L., et al. Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996, 347:422-425.
24. Shiozaki A., Niiya K., Higuchi F., Tashiro S., Arai T., Izumi R., et al. Ellagic acid/phospholipid-induced coagulation and dextran sulfate-induced fibrinolytic activities in beta 2-glycoprotein I-depleted plasma. Thrombosis Research 1994, 76:199-210.
25. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. Journal of Cerebral Blood Flow and Metabolism 1981, 1:53-60.
26. Tomizawa S., Imai H., Tsukada S., Simizu T., Honda F., Nakamura M., et al. The detection and quantification of highly reactive oxygen species using the novel HPF fluorescence probe in a rat model of focal cerebral ischemia. Neuroscience Research 2005, 53:304-313.
27. Xiao X., Liu J., Hu J., Li T., Zhang Y. Protective effect of protopine on the focal cerebral ischaemic injury in rats. Basic & Clinical Pharmacology & Toxicology 2007, 101:85-89.
28. Zhang Z., Zhang R.L., Jiang Q., Raman S.B., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 1997, 17:123-135.